Avoiding a paper on Marcus Aurelius, I started poking around the BBC website, and found these two related stories;
Feature, or bug?
Healthcare providers have also complained that because of the scarcity of crucial medicines, distributors have been selling drugs in the “grey market” at 100-fold more than their usual retail prices.
There’s this worrisome bit, though;
However it could take around 18 months for new production to reach the market, the FDA has said.
Erin Fox, pharmacist at the University of Utah says just a handful of companies are the main suppliers for many of the drugs in short supply.
A number of their manufacturing facilities were recently shut for safety upgrades. Shortages of some ingredients are also behind the bottleneck in supply.
But James Speyer, medical director of the clinical cancer centre at New York University’s Langone Medical Center, says the president’s action does not address one key part of the problem – drug profits.
Many of the scarce drugs are cheaper generics that yield low profits to their manufacturers.
However, I’m sure this part of the problem has been “taken care of:” from September 2010;